Articles From: BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines to BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS


SAN RAFAEL, Calif., Sept.
Sign-up for BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines investment picks
SAN RAFAEL, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that it has sold the Rare Pediatric Disease Priority Review Voucher (PRV) it obtained in February of this year.
Sign-up for BioMarin Sells Priority Review Voucher for $67.5 Million investment picks
- Jefferies Gene Therapy Summit on September 30 in Boston SAN RAFAEL, Calif., Sept.
Sign-up for BioMarin to Attend Upcoming Investor Conferences investment picks
- J.P. Morgan Annual U.S. All Stars Conference in London on September 16 SAN RAFAEL, Calif., Sept.
Sign-up for BioMarin to Attend Upcoming Investor Conferences in London investment picks
SAN RAFAEL, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) , a global leader in the development and commercialization of therapies for rare genetic diseases, today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, July 30, at 4:30 p.m. ET to discuss second quarter 2014 financial results and provide a general business update.
Sign-up for BioMarin to Host Second Quarter 2014 Financial Results Conference Call and Webcast on Wednesday, July 30 at 4:30pm ET investment picks
- Baird 2014 Healthcare Conference on September 3 - Citi Annual Biotech Conference on September 4 - Morgan Stanley Global Healthcare Conference on September 9 SAN RAFAEL, Calif., Aug.
Sign-up for BioMarin to Present at Upcoming Investor Conferences investment picks
Global BioPharmaceutical Leader Leases an Additional 61,000 Square Feet to Grow Its Presence and Research Capabilities in the Bay Area SAN DIEGO , July 24, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Bristol-Myers Squibb (NYSE: BMY) has signed a ten-year lease for approximately 61,000 square feet of additional laboratory and office space at the company's Woodside Technology Park life science campus in Redwood City, California .
Sign-up for BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To 194,100 Square Feet At Woodside Technology Park In Redwood City, California investment picks
The New BioMed Realty Research Center Signs First Tenant to 25,000 Square Feet in the New Building As the Life Science Community Continues Growing in South Lake Union SEATTLE , Aug.
Sign-up for BioMed Realty Breaks Ground On New 122,000 Square Foot State-Of-The-Art Laboratory And Office Building Creating New Life Science Hub In Seattle investment picks
Biotechnology Company Leases 33,800 SF Following Its Successful IPO in January ROCKVILLE, Md.
Sign-up for BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland investment picks
SAN DIEGO , Sept.
Sign-up for BioMed Realty Trust Declares Third Quarter 2014 Common Stock Dividend investment picks
Second Quarter Leasing Volume Exceeds 810,000 SF; FFO of $0.40 per Diluted Share SAN DIEGO , Aug.
Sign-up for BioMed Realty Trust Reports Second Quarter 2014 Financial Results investment picks
Global Healthcare Company to Expand into 200,000 Square Feet in 650 East Kendall Street Property CAMBRIDGE, Mass.
Sign-up for BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts investment picks
SAN DIEGO, July 8, 2014 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its second quarter ended June 30, 2014 after the market closes on Tuesday, August 5, 2014.
Sign-up for BioMed Realty Trust to Report 2014 Second Quarter Results investment picks
SAN DIEGO , Aug.
Sign-up for BioMed Realty Trust To Webcast Investor Day 2014 investment picks
http://media.marketwire.com/attachments/200704/326043_NewBiomericaLogo150.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141343&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for Biomerica Announces Year End Results investment picks
BELLEVILLE, ON , July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer.
Sign-up for Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States investment picks
BELLEVILLE, ON , July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer.
Sign-up for Bioniche Announces Submission of Orphan Drug Designation Application for MCNA in the United States investment picks
Bioniche Files Final Prospectus For Equity Offering Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ./ BELLEVILLE, ON , Sept.
Sign-up for Bioniche Files Final Prospectus For Equity Offering investment picks
Bioniche Life Sciences Closes Equity Offering Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ./ BELLEVILLE, ON , Sept.
Sign-up for Bioniche Life Sciences Closes Equity Offering investment picks
(all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON , Sept.
Sign-up for Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results investment picks
Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results Canada NewsWire (all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON , Sept.
Sign-up for Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results investment picks
http://media.marketwire.com/attachments/201312/69900_StockMarketMediaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145119&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Bioniche Life Sciences Receives Coverage as Highly Undervalued Biopharmaceutical investment picks
2014/9/8
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141874&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Appoints Paul B. Savoldelli to Its Board investment picks
2014/9/4
http://media.marketwire.com/attachments/201409/78876_bion.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142005&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Enters Into a $5 Million Loan for Taylor County Plant investment picks
2014/9/24
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147007&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen President & CFO to Take Leave of Absence investment picks
2014/7/17
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131775&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Receives Incentives Approvals From Taylor County for up to $220 Million in Investments for the Taylor County Plant investment picks
2014/7/29
BOSTON , MASS., July 29, 2014 (GLOBE NEWSWIRE) -- Polaris Partners today announced the hiring of biopharmaceutical executive Amy Schulman as a Venture Partner, based out of Boston.
Sign-up for BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines to BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices